Form 4: VolitionRx CEO Butera Reports RSU Tax Withholding

Salvatore Thomas Butera, CEO of Volition Veterinary, reported the disposition of 5,230 VolitionRx common shares for tax withholding related to restricted stock unit settlement.

Summary

• Salvatore Thomas Butera, CEO of Volition Veterinary, reported a transaction involving VolitionRx Ltd. common stock.
• The transaction, dated September 28, 2025, involved the disposition of 5,230 shares.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations upon the settlement of 19,125 restricted stock units.
• No shares were sold by the reporting person or VolitionRx in this transaction; it was solely for tax purposes.
• The price per share for the tax withholding was $0.605.
• Following this transaction, Mr. Butera directly owns 332,285 shares and jointly owns 99,350 shares with his spouse.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to executive compensation, indicating neither positive nor negative sentiment regarding the company's operational or financial performance.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation, common across all industries for publicly traded companies. It does not reflect broader industry trends.

Comparison to Industry Standards

• NA. This is a standard mechanism for settling restricted stock units and covering tax obligations, consistent with common executive compensation practices in publicly traded companies.

Stakeholder Impact

• Minimal direct impact on shareholders as it's a routine compensation-related tax withholding. It reflects the ongoing compensation structure for a key executive.

Key Dates

Keywords

VolitionRx, VNRX, Salvatore Thomas Butera, Insider Transaction, Form 4, Restricted Stock Units, RSU, Tax Withholding, CEO, Volition Veterinary